468 related articles for article (PubMed ID: 33586248)
21. Anti-Angiogenic Therapy: Current Challenges and Future Perspectives.
Lopes-Coelho F; Martins F; Pereira SA; Serpa J
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916438
[TBL] [Abstract][Full Text] [Related]
22. Extracellular vesicles in tumor angiogenesis and resistance to anti-angiogenic therapy.
Ye ZW; Yu ZL; Chen G; Jia J
Cancer Sci; 2023 Jul; 114(7):2739-2749. PubMed ID: 37010195
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive landscape of extracellular vesicle-derived RNAs in cancer initiation, progression, metastasis and cancer immunology.
Hu W; Liu C; Bi ZY; Zhou Q; Zhang H; Li LL; Zhang J; Zhu W; Song YY; Zhang F; Yang HM; Bi YY; He QQ; Tan GJ; Sun CC; Li DJ
Mol Cancer; 2020 Jun; 19(1):102. PubMed ID: 32503543
[TBL] [Abstract][Full Text] [Related]
24. Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance.
Maacha S; Bhat AA; Jimenez L; Raza A; Haris M; Uddin S; Grivel JC
Mol Cancer; 2019 Mar; 18(1):55. PubMed ID: 30925923
[TBL] [Abstract][Full Text] [Related]
25. Glucocorticoid-mediated effects on angiogenesis in solid tumors.
Martens B; Drebert Z
J Steroid Biochem Mol Biol; 2019 Apr; 188():147-155. PubMed ID: 30654109
[TBL] [Abstract][Full Text] [Related]
26. Tetrac as an anti-angiogenic agent in cancer.
Schmohl KA; Nelson PJ; Spitzweg C
Endocr Relat Cancer; 2019 Jun; 26(6):R287-R304. PubMed ID: 31063970
[TBL] [Abstract][Full Text] [Related]
27. Trends and Challenges in Tumor Anti-Angiogenic Therapies.
Jászai J; Schmidt MHH
Cells; 2019 Sep; 8(9):. PubMed ID: 31540455
[TBL] [Abstract][Full Text] [Related]
28. Extracellular vesicle docking at the cellular port: Extracellular vesicle binding and uptake.
French KC; Antonyak MA; Cerione RA
Semin Cell Dev Biol; 2017 Jul; 67():48-55. PubMed ID: 28104520
[TBL] [Abstract][Full Text] [Related]
29. Role of mesenchymal stromal cell-derived extracellular vesicles in tumour microenvironment.
Adamo A; Dal Collo G; Bazzoni R; Krampera M
Biochim Biophys Acta Rev Cancer; 2019 Jan; 1871(1):192-198. PubMed ID: 30599188
[TBL] [Abstract][Full Text] [Related]
30. Cancer stem cells and their vascular niche: Do they benefit from each other?
Ping YF; Zhang X; Bian XW
Cancer Lett; 2016 Oct; 380(2):561-567. PubMed ID: 25979233
[TBL] [Abstract][Full Text] [Related]
31. Anti-angiogenic alternatives to VEGF blockade.
Khan KA; Bicknell R
Clin Exp Metastasis; 2016 Feb; 33(2):197-210. PubMed ID: 26620208
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of Drug Resistance in Cancer: The Role of Extracellular Vesicles.
Samuel P; Fabbri M; Carter DRF
Proteomics; 2017 Dec; 17(23-24):. PubMed ID: 28941129
[TBL] [Abstract][Full Text] [Related]
33. Extracellular vesicles of multiple myeloma cells utilize the proteasome inhibitor mechanism to moderate endothelial angiogenesis.
Zarfati M; Avivi I; Brenner B; Katz T; Aharon A
Angiogenesis; 2019 Feb; 22(1):185-196. PubMed ID: 30386953
[TBL] [Abstract][Full Text] [Related]
34. The Roles of Extracellular Vesicles in Malignant Melanoma.
Cheng YC; Chang YA; Chen YJ; Sung HM; Bogeski I; Su HL; Hsu YL; Wang HD
Cells; 2021 Oct; 10(10):. PubMed ID: 34685720
[TBL] [Abstract][Full Text] [Related]
35. Shedding of bevacizumab in tumour cells-derived extracellular vesicles as a new therapeutic escape mechanism in glioblastoma.
Simon T; Pinioti S; Schellenberger P; Rajeeve V; Wendler F; Cutillas PR; King A; Stebbing J; Giamas G
Mol Cancer; 2018 Aug; 17(1):132. PubMed ID: 30165850
[TBL] [Abstract][Full Text] [Related]
36. Natural melanoma-derived extracellular vesicles.
Hood JL
Semin Cancer Biol; 2019 Dec; 59():251-265. PubMed ID: 31386906
[TBL] [Abstract][Full Text] [Related]
37. Extracellular Vesicles and Carried miRNAs in the Progression of Renal Cell Carcinoma.
Grange C; Brossa A; Bussolati B
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013896
[TBL] [Abstract][Full Text] [Related]
38. The Yin and Yang of tumour-derived extracellular vesicles in tumour immunity.
Yamauchi T; Moroishi T
J Biochem; 2021 Mar; 169(2):155-161. PubMed ID: 33226400
[TBL] [Abstract][Full Text] [Related]
39. Resistance and escape from antiangiogenesis therapy: clinical implications and future strategies.
Bottsford-Miller JN; Coleman RL; Sood AK
J Clin Oncol; 2012 Nov; 30(32):4026-34. PubMed ID: 23008289
[TBL] [Abstract][Full Text] [Related]
40. Novel anti-angiogenic therapies for malignant gliomas.
Norden AD; Drappatz J; Wen PY
Lancet Neurol; 2008 Dec; 7(12):1152-60. PubMed ID: 19007739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
